Access and Evidence
Embracing Early Access
Compassionate use programs offer hope to patients who have ran out of options. But the benefits must be weighed against the risks.
More Access and Evidence Articles
Access and Evidence
RWE: The Missing Link
Linking real-world datasets is essential to deliver true insights
Access and Evidence
Gold Standard: Standardizing RWD
If real-world data is to deliver on its promise, it needs to be standardized
Access and Evidence
Blockchain: Solution Or Snake Oil?
The potential of blockchain to better manage RWE and access makes it an exciting prospect. However, pharma first needs to get its head around the practical application.
Access and Evidence
VBCs: Are They Working?
Are value-based contracts actually improving patient access to new medicines?
Access and Evidence
Calling the Shots?
How influential are the value assessments from bodies like ICER?
Access and Evidence
Value-Based Contracting: Do We Have The Data?
Deals have been signed. Promises have been made. But are companies delivering the goods?
Access and Evidence
How To Illustrate Your RWE To Payers
Data visualization tools are demystifying real-world evidence.
Access and Evidence
American Healthcare System 1 - 0 Europe
When it comes to pricing and access, the European healthcare system is losing.